(Q33491133)

27 July 2017

title

Suramin in adrenocortical cancer: limited efficacy and serious toxicity (English)

1 reference

27 July 2017

1 reference

Arlt W

1

1 reference

27 July 2017

Reincke M

2

1 reference

27 July 2017

Siekmann L

3

1 reference

27 July 2017

Winkelmann W

4

1 reference

27 July 2017

Allolio B

5

1 reference

27 July 2017

publication date

1 September 1994

1 reference

27 July 2017

published in

Clinical Endocrinology

1 reference

27 July 2017

volume

41

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

299-307

1 reference

Double screening of suramin derivatives on human colon cancer cells and on neural cells provides new therapeutic agents with reduced toxicity

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Experimental animal model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Surface sulfated mucopolysaccharides of primary and permanent mammalian cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Effects of suramin on complement, blood clotting, fibrinolysis and kinin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Synergistic activity of suramin with tumor necrosis factor alpha and doxorubicin on human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Suramin binds to platelet-derived growth factor and inhibits its biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Lack of response to suramin in patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Suramin-induced polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Fatal toxic epidermal necrolysis during suramin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Suramin enhancement of the chemotherapeutic actions of cyclophosphamide or adriamycin of intramuscularly-implanted Ehrlich carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Radiation therapy of adrenal cortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Impairment of adrenocortical function associated with increased plasma tumor necrosis factor-alpha and interleukin-6 concentrations in African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Immune-mediated thrombocytopenia secondary to suramin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02549.X

10.1111/J.1365-2265.1994.TB02549.X

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference